amiodarone

1. The use of amiodarone had no significant effects on the primary quality-of-life outcomes.
   应用胺碘酮对主要生命质量预后没有改善。
2. Objective: To compare the efficacy and safety of intravenous amiodarone and propafenone for broad QRS tachycardia.
   目的：观察和比较静脉注射胺碘酮、普罗帕酮治疗宽QRS波群心动过速的即时疗效和安全性。
3. The Clinical Efficacy of Large-dosage Amiodarone in Treating Refractory Ventricular Tachycardia and/ or Ventricular Fibrillation in Emergency Department
   急诊大剂量静脉应用胺碘酮治疗顽固性室性心动过速和/或心室颤动的疗效观察
4. Objective To evaluate and synthesize evidence regarding optimal use of amiodarone for various arrhythmias.
   目的：评估和总结胺碘酮对各种心律失常的最适使用证据。
5. These observational findings are in contrast to earlier randomized trials of amiodarone and need to be validated prospectively.
   这些观察结果与更早期进行的胺碘酮随机化试验相反，这需要将来的进一步验证。
6. To establish a method for the determination of dissolution of amiodarone hydrochloride tablets.
   目的：建立盐酸胺碘酮片的溶出度测定方法。
7. CONCLUSION: In this study, amiodarone use was associated with excess early and late all-cause and cardiovascular mortality.
   结论：在该研究中，胺碘酮的使用与过早的晚期所有原因引起的心血管死亡率有关。
8. Pharmacokinetics of Amiodarone Dispersible Tablets in Human Plasma
   人血浆中胺碘酮分散片的药动学研究
9. Current Situation of Application of Amiodarone in Treatment of Arrhythmia
   胺碘酮在心律失常治疗中的应用现状
10. Amiodarone also acts as a thyroid hormone receptor antagonist.
    胺碘酮也可作为甲状腺激素受体拮抗剂。
11. Arrhythmia was finally controlled with amiodarone and digoxin.
    最后，心律不齐被胺碘酮和地高辛控制。
12. Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia
    胺碘酮和美托洛尔治疗慢性心功能不全合并室性心律失常的疗效分析
13. Amiodarone Acute myocardial infarction Fast atrial fibrillation;
    胺碘酮；急性心肌梗塞；快速房颤；
14. Study on Prophylactic Application of Amiodarone in Treatment of Acute Myocardial Infarction in Pre-hospital Care
    胺碘酮在急性心肌梗死院前急救中预防性应用的研究
15. Treatment efficacy of amiodarone and cedilanid on paroxysmal atrial fibrillation
    胺碘酮和西地兰治疗阵发性房颤的疗效分析
16. Compared with placebo, amiodarone had no significant effect on any mode of death.
    与安慰剂相比，胺碘酮对任何形式的死亡率都无显著影响。
17. The only role for prophylactic amiodarone is in the perioperative period of cardiac surgery.
    胺碘酮的唯一预防性使用适应症是心脏外科手术期间。
18. Clinical efficacy of enalapril and amiodarone in patients with paroxysmal atrial fibrillation
    胺碘酮与依那普利联合治疗阵发性心房颤动的临床研究
19. CONCLUSION: Low dosage of amiodarone is effective in treating AMI complicated with tachyarrhythmia with mild adverse drug reactions.
    结论：小剂量胺碘酮治疗AMI合并快速型心律失常作用可靠，值得应用。
20. Amiodarone influences thyroid hormone secretion and metabolism in all patients taking the drug.
    胺碘酮影响所用服用这种药物的患者的甲状腺激素的分泌和代谢。
21. Current preventive strategies include the use of beta-blockers and antiarrhythmic drugs such as amiodarone and sotalol.
    目前预防的主要措施包括：β受体阻滞剂的及抗心率失常药的使用，如胺碘酮和索他洛尔。
22. Class III anti-arrhythmic drugs ( such as amiodarone) act ia prolongation of the action potential.
    III类抗心律失常药物（例如胺碘酮）是通过延长动作电位来发挥作用的。
23. To compare the safety and efficacy of amiodarone and cedilanid on the treatment of paroxysmal atrial fibrillation.
    目的对比胺碘酮与西地兰治疗阵发性心房颤动的疗效及安全性。
24. Objective: To explore the effect of combined therapy of amiodarone and valsartan on paroxysmal atrial fibrillation.
    目的：探讨胺碘酮联合缬沙坦治疗阵发性房颤的临床效果。
25. Objective To evaluate the therapeutic effect of amiodarone on refractory ventricular premature systole and its safe.
    目的评价口服胺碘酮治疗难治性室性期前收缩的疗效和安全性。
26. Objective To discuss the clinical efficacy and safety of the combination of amiodarone and benazapril in treatment of paroxysmal atrial fibrillation.
    目的探讨胺碘酮和贝那普利联合用药治疗阵发性心房颤动的临床疗效和安全性。
27. Objective To explore the clinical effect of Wenxin Grain combined with Amiodarone in the treatment of chronic atrial fibrillation.
    目的探讨稳心颗粒与乙胺碘肤酮联用治疗慢性房颤的临床疗效。
28. Effects of Sodium Ferulate on Ionic Channel Currents in Rabbit Ventricular Myocytes: Comparison with Amiodarone
    阿魏酸钠与胺碘酮对家兔心室肌细胞离子通道电流作用的对比实验研究
29. Objective To investigate the effect of amiodarone combined with atorvastatin on CRP and recurrence rate of atrial fibrillation for patients with paroxysmal atrial fibrillation.
    目的探讨胺碘酮联合阿托伐他汀对阵发性房颤患者CRP和房颤复发率的影响。

noun

1. an antiarrhythmic drug (trade name Cordarone) that has potentially fatal side effects and is used to control serious heart rhythm problems only when safer agents have been ineffective

   Synonym:    Cordarone